357 related articles for article (PubMed ID: 34050566)
1. Role of CXCR4 in the progression and therapy of acute leukaemia.
Su L; Hu Z; Yang YG
Cell Prolif; 2021 Jul; 54(7):e13076. PubMed ID: 34050566
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
[TBL] [Abstract][Full Text] [Related]
3. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia.
van den Berk LC; van der Veer A; Willemse ME; Theeuwes MJ; Luijendijk MW; Tong WH; van der Sluis IM; Pieters R; den Boer ML
Br J Haematol; 2014 Jul; 166(2):240-9. PubMed ID: 24697337
[TBL] [Abstract][Full Text] [Related]
4. [CXCR4: a new therapeutic target of the leukaemic cell? Role of the SDF-1/CXCR4 axis in acute myeloid leukaemia].
Tavernier E; Aanei C; Solly F; Flandrin-Gresta P; Campos L; Guyotat D
Bull Cancer; 2014 Jun; 101(6):593-604. PubMed ID: 24977448
[TBL] [Abstract][Full Text] [Related]
5. [Level of SDF-1/CXCR4 in children with acute leukemia and its significance].
Wen Q; Chen RL; Cai KR; Lin YW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):324-6. PubMed ID: 21518481
[TBL] [Abstract][Full Text] [Related]
6. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies.
Peled A; Klein S; Beider K; Burger JA; Abraham M
Cytokine; 2018 Sep; 109():11-16. PubMed ID: 29903571
[TBL] [Abstract][Full Text] [Related]
7. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia.
Möhle R; Schittenhelm M; Failenschmid C; Bautz F; Kratz-Albers K; Serve H; Brugger W; Kanz L
Br J Haematol; 2000 Sep; 110(3):563-72. PubMed ID: 10997965
[TBL] [Abstract][Full Text] [Related]
8. Posttransplant blockade of CXCR4 improves leukemia complete remission rates and donor stem cell engraftment without aggravating GVHD.
Su L; Fang MH; Zou J; Gao SJ; Gu XY; Meng XD; Wang X; Hu Z; Yang YG
Cell Mol Immunol; 2021 Nov; 18(11):2541-2553. PubMed ID: 34635806
[TBL] [Abstract][Full Text] [Related]
9. [The expression and clinical significance of stromal cell-derived factor-1 and CXCR4 in acute leukemia and malignant lymphoma].
Zeng DF; Kong PY; Chen XH; Wei L; Chang C; Peng XG
Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):522-4. PubMed ID: 16080846
[TBL] [Abstract][Full Text] [Related]
10. Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemia.
Randhawa S; Cho BS; Ghosh D; Sivina M; Koehrer S; Müschen M; Peled A; Davis RE; Konopleva M; Burger JA
Br J Haematol; 2016 Aug; 174(3):425-36. PubMed ID: 27071778
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation.
Ngamsri KC; Jans C; Putri RA; Schindler K; Gamper-Tsigaras J; Eggstein C; Köhler D; Konrad FM
Front Immunol; 2020; 11():407. PubMed ID: 32210974
[TBL] [Abstract][Full Text] [Related]
12. Role of CXCR4 in the pathogenesis of acute myeloid leukemia.
Peled A; Tavor S
Theranostics; 2013; 3(1):34-9. PubMed ID: 23382784
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow.
Adamiak M; Borkowska S; Wysoczynski M; Suszynska M; Kucia M; Rokosh G; Abdel-Latif A; Ratajczak J; Ratajczak MZ
Oncotarget; 2015 Aug; 6(22):18819-28. PubMed ID: 26299919
[TBL] [Abstract][Full Text] [Related]
14. Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model.
Goodrich AD; Varain NM; Jeanblanc CM; Colon DM; Kim J; Zanjani ED; Hematti P
Cytotherapy; 2014 Sep; 16(9):1280-93. PubMed ID: 25108653
[TBL] [Abstract][Full Text] [Related]
15. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.
Crazzolara R; Kreczy A; Mann G; Heitger A; Eibl G; Fink FM; Möhle R; Meister B
Br J Haematol; 2001 Dec; 115(3):545-53. PubMed ID: 11736934
[TBL] [Abstract][Full Text] [Related]
16. The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target.
Burger JA; Bürkle A
Br J Haematol; 2007 May; 137(4):288-96. PubMed ID: 17456052
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment.
Juarez J; Dela Pena A; Baraz R; Hewson J; Khoo M; Cisterne A; Fricker S; Fujii N; Bradstock KF; Bendall LJ
Leukemia; 2007 Jun; 21(6):1249-57. PubMed ID: 17410186
[TBL] [Abstract][Full Text] [Related]
18. Identification of hepatic niche harboring human acute lymphoblastic leukemic cells via the SDF-1/CXCR4 axis.
Kato I; Niwa A; Heike T; Fujino H; Saito MK; Umeda K; Hiramatsu H; Ito M; Morita M; Nishinaka Y; Adachi S; Ishikawa F; Nakahata T
PLoS One; 2011; 6(11):e27042. PubMed ID: 22069486
[TBL] [Abstract][Full Text] [Related]
19. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
Han AR; Lee JY; Kim HJ; Min WS; Park G; Kim SH
Oncol Rep; 2015 Dec; 34(6):2880-8. PubMed ID: 26398122
[TBL] [Abstract][Full Text] [Related]
20. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
Tavor S; Petit I
Semin Cancer Biol; 2010 Jun; 20(3):178-85. PubMed ID: 20637871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
